Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients
Clinical trial NCT05603845 · COMPLETED
Trial details
- NCT number
- NCT05603845
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-20
- Primary completion
- 2025-04-10
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.